Search alternatives:
decrease processes » disease processes (Expand search), decay processes (Expand search), increase process (Expand search)
decrease decrease » decrease release (Expand search), disease decreases (Expand search), decreases disease (Expand search)
drugs decrease » drugs increases (Expand search), drugs release (Expand search)
decrease after » increase after (Expand search), disease after (Expand search)
decrease processes » disease processes (Expand search), decay processes (Expand search), increase process (Expand search)
decrease decrease » decrease release (Expand search), disease decreases (Expand search), decreases disease (Expand search)
drugs decrease » drugs increases (Expand search), drugs release (Expand search)
decrease after » increase after (Expand search), disease after (Expand search)
1
“... (9 vs. 7, p < 0.0001), required more vasoactive drugs [82.2% vs. 55.1%, p < 0.0001] and renal replacement therapies...”
Access document
Access document
Article
2
“... (9 vs. 7, p < 0.0001), required more vasoactive drugs [82.2% vs. 55.1%, p < 0.0001] and renal replacement therapies...”
Access document
Access document
Article
3
4
“... lactate, and use of vasoactive drugs at 48 hours after IABP insertion. The 30-day mortality was estimated...”
Access document
Access document
Article
5
“... drugs were excluded. Saline loads were infused before and after the AmphoB treatment. Blood and urine...”
Access document
Access document
Article
6
“... on the infusion of fluids and vasoactive drugs, mechanical ventilation, and triggering factor correction...”
Access document
Access document
Article
7
8
9
10
11
12
“... by this overload, vasoactive drugs with vasopressor and inotropic properties are commonly administered...”
Access document (1)
Access document (2)
Access document (1)
Access document (2)
Doctoral thesis
13
14
15
16
“... cannulated to evaluate their pressure variation after addition of vasoactive drugs. Internal organs were...”
Access document
Access document
Doctoral thesis
17
“... interfering factors were: tube feeding repositioning (phase 1 16.0%; phase 2 17.0%), vasoactive drugs...”
Access document
Access document
Master thesis
18
19
20